PGY-2 Pediatric Pharmacy Residency

The MUSC PGY2 Pediatrics Pharmacy residency has trained pediatric pharmacists for more than 30 years with more than 60 residents having successfully completed the program and obtained successful employment.

The PGY-2 Pediatric Pharmacy Residency is a one-year program designed to build upon the resident's Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency program to contribute to the development of a clinical pharmacist specialized in the care of children in a variety of pediatric practice environments. The PGY2 Pediatric Pharmacy residency provides the resident with opportunities to function independently as a practitioner by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice functions. Residents also will continue to develop skills in patient- and family-centered care and pharmacy operational services.

The residency program is designed to develop practice patterns, expert knowledge, skills, attitudes, and abilities in the area of pediatric pharmacy practice. The residency program builds on the broad-based competencies achieved in a PGY1 residency, transitioning the resident from generalist care to providing specialized care to children. It will equip the resident to participate as an integral member of an interdisciplinary team caring for children, assuming responsibility for the care of these patients. The residency provides opportunities to function independently as a practitioner by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved drug therapy outcomes for children. The residency provides opportunities for teaching, research, and leadership. A resident who successfully completes this residency will possess competencies that enable success as a clinical pharmacist in any chosen area of clinical practice, success as a clinical faculty member with responsibilities for patient care and precepting pharmacy students and residents, and attainment of board certification in Pediatrics (BCPPS).

The resident is expected to achieve all the goals specified by the American Society of Health-system Pharmacists (ASHP) Accreditation Standards for PGY2 Pediatric Pharmacy residents. Resident-specific goals and objectives will be established and modified according to the resident's interests and previous experiences. The resident will be expected to advance to meet the following outcomes:

  • Serve as an authoritative resource on the optimal use of drugs in children;
  • Contribute to the development and monitoring of nutrition care plans for children;
  • Optimize the outcomes of the care of children by providing evidence-based, patient-centered drug therapy as an integral part of an interdisciplinary team in a variety of practice areas;
  • Manage and improve the medication-use process for children;
  • Exercise leadership and practice management skills;
  • Demonstrate excellence in the provision of medication- and practice-related education and training;
  • Conduct and publish pediatric pharmacy-related practice research;
  • Use medical informatics efficiently;
  • Promote health improvement, wellness, and disease prevention; and
  • Sustain ongoing personal professional development.

Kathy Chessman, PharmD, FPPA, FCCP, BCPS, BCNSP; Clinical Pharmacy Specialist, Pediatrics/Surgery; Professor and Chair, Clinical Pharmacy and Outcomes Sciences
Toby Cox, PharmD, BCPS; Clinical Pharmacy Specialist, Pediatrics/Neonatology; Affiliate Assistant Professor, Clinical Pharmacy and Outcomes Sciences
Sandra Garner, PharmD, FCCP, BCPS, BCPPS; Clinical Pharmacy Specialist, Pediatrics/Neonatology; Professor, Clinical Pharmacy and Outcome Sciences
Lauren Haney, PharmD; BCPS, BCPPS, Clinical Pharmacy Specialist, Pediatrics/ Cardiothoracic Surgery/Cardiology; Affiliate Assistant Professor; Clinical Pharmacy and Outcomes Sciences
Julie Heh, PharmD; BCPS, BCPPS, Clinical Pharmacy Specialist, Pediatrics/Hematology/ Oncology; Affiliate Assistant Professor, Clinical Pharmacy and Outcomes Sciences
Liz LaScala, PharmD, BCPS; Clinical Pharmacist, Shawn Jenkins Children's Hospital
Katie Malloy, PharmD, BCPPS; Clinical Pharmacy Specialist; Pediatrics/Neonatology Affiliate Assistant Professor, Clinical Pharmacy and Outcomes Sciences
Taylor Morrisette, Pharm.D., M.P.H. Candidate; Clinical Pharmacy Specialist, Infectious Diseases and Antimicrobial Stewardship; Assistant Professor, Clinical Pharmacy and Outcomes Sciences
Colleen Scherer, PharmD, MPA, BCPS; Pharmacy Manager, Children's Hospital Pharmacy and Summey Medical Pavilion
Megan Sell, PharmD, BCPS; Clinical Pharmacy Specialist, General Pediatrics/Transplant/Pediatric Surgery 
Kathy Sprott, PharmD, BCPS; BCPPS, Clinical Pharmacy Specialist, Pediatrics/Transplant; Affiliate Assistant Professor, Clinical Pharmacy and Outcomes Sciences
Jill Thompson, PharmD, BCPPS; Pediatric Clinical Pharmacy Coordinator; Clinical Pharmacy Specialist, Pediatric ICU/Surgery; Affiliate Associate Professor, Clinical Pharmacy and Outcomes Sciences.

The resident will have the opportunity to participate in the care of inpatient and ambulatory patients through monthly clinical rotations, longitudinal clinics, and other activities. There are eight core (required) learning experiences. Electives (2-3 months) will be targeted to the resident’s interests, are flexible, and are available in a wide variety of areas.

Orientation (if non-MUSC PGY1) | 1 month (July)
General Pediatrics | 1 month
Pediatric Surgery | 1 month
Pediatric Intensive Care | 2 months
Neonatal Intensive Care | 2 months
Pediatric Cardiothoracic Intensive Care | 1 month
Pediatric Hematology/Oncology | 1 month
Clinical Teaching | 1 month
Electives (various) | 2 months
Ambulatory Care Clinic | Longitudinal, one half-day per week.

Clinical Staffing
Residents will gain clinical experience providing service throughout the year as a clinical pharmacist in the Children’s Hospital Pharmacy. PGY2 Pediatric Pharmacy residents will staff 16 hours per month. Residents will be scheduled in a variety of roles. Activities will include, but are not limited to, medication reconciliation, order verification including parenteral nutrition verification, sterile product verification, attending emergency codes, delivering patient education, and answering drug information questions. Residents will be evaluated quarterly on this learning experience.

Pediatric Clinical On-Call Service
Residents will participate in the Pediatric Clinical Pharmacy On-Call Service which provides 24-hour clinical pharmacy services. Residents will serve as the primary on-call provider with a clinical pharmacy specialist as back-up preceptor approximately one week per month. All clinical recommendations are reviewed with the back-up. On-call responsibilities include, but are not limited to, monitoring of patients receiving anticoagulants, aminoglycosides, vancomycin, and other high-risk medications; ordering parenteral nutrition; answering drug information questions; and monitoring complex patients. The resident will be evaluated on this learning experience at least three times each year.

Research Project
Each resident will complete a major service or research project during the year. Project ideas will be generated by care team members of MUSC Health to address clinical and operational needs for Pharmacy Services and patients of the MUSC Children's Hospital. The resident will present the results of their project at a local, state, regional, or national meeting, and they must write a manuscript suitable for publication describing the results of the project. Residents will be provided one working day each month to work on the project. The resident's progress will be evaluated on this learning experience quarterly.

Pediatric Ambulatory Care Clinic
Residents will participate in a specialized pediatric ambulatory care clinic approximately 16 hours per month. Activities include medication histories, medication and vaccination optimization, drug information, and medication counseling. Current clinic opportunities include Cystic Fibrosis, Solid Organ Transplant, and Oncology.

To ensure advancement of education and training skills, the resident will be required to:

  • provide at least one lecture to Doctor of Pharmacy students and one ACPE-accredited seminar;
  • co-precept PharmD students on pediatric rotations;
  • lead case presentations, code refreshers, and patient presentations;
  • evaluate Doctor of Pharmacy student Grand Rounds presentations;
  • provide in-service education; and
  • facilitate pediatric journal club.

Academic Preparation Program (APP)
The MUSC College of Pharmacy offers an optional certificate to residents who are interested in enhancing skills needed in an academic environment. Residents are assigned a faculty mentor for this program. Requirements for APP include providing two hours of didactic lectures, developing a complex patient case, facilitating five small group discussions and/or laboratory exercises, and serving as a co-preceptor for two students on APPE rotations.

Research Certificate Program
The MUSC College of Pharmacy also offers a research certificate program for residents, consisting of live sessions aimed at improving the resident’s ability to conduct, disseminate, and interpret research.

Residents and preceptors will use PharmAcademic to complete evaluations throughout the year for all learning experiences. The resident is expected to successfully complete and achieve all of the required outcomes and 80% of the elective outcomes assigned according to the ASHP Educational Outcomes, Goals, and Objectives for PGY2 Pharmacy Practice residents as assessed by the Residency Program Director at the last quarterly evaluation.

Specifics regarding residency and preceptor evaluation responsibilities and expectations can be found in the Residency Manual.

For each learning experience, the resident will complete a summative self-evaluation of applicable goals and objectives, an evaluation of the learning experience, and an evaluation of the preceptor. The preceptor completes an initial learning experience introduction, a midpoint evaluation, and a final evaluation that details the resident’s performance related to the identified learning objects that correlate with the learning experience as well as any additional areas of pharmacy practice.

Resident Stipend: assessed annually and communicated in the employment letter

Leave: 23 days of paid leave for sick leave, vacation time, holidays, and interview days.
Administrative time is granted for attendance at professional meetings or other duties, if approved by the RPD. Long-term leave (maximum, 8 weeks) is available through a combination of paid leave and/or leave without pay.

Health Insurance: Medical and dental insurance is available through MUSC Health.

Parking: Parking at MUSC Health is available for a monthly charge.

Technology: Residents will be provided a laptop and a pager to use throughout the year.

Travel: Each resident is given a stipend to assist in travel expenses for professional meetings based on funding availability and as approved by MUSC.

  • Pharmacy licensure in South Carolina by July 1; if unable to be licensed by September 30, the resident will be dismissed.
  • Complete BLS and PALS. (May be accomplished in PGY1 year with certificate that expires after June 30 of residency year.)
  • Complete all required rotation experiences to the satisfaction of the rotation preceptor and RPD.
  • Complete all assignments in PharmAcademic.
  • Complete initial and quarterly updates to the development plan. Complete end-of-year self-assessment and review with RPD.
  • Attain ‘Achieved’ on 100% of the ASHP goals and objectives for the PGY2 Pediatric Pharmacy residency
  • Complete all staffing requirements achieving “Achieved” on all goals and objectives in the learning experience.
  • Participate in the Pediatric Clinical Pharmacy On-call Service and achieve “Achieved” all goals and objectives in the learning experience.
  • Prepare and present an ACPE-approved continuing education seminar and receive positive evaluations.
  • Complete a research project designed to improve the services of the Pharmacy ICCE, specifically in the MUSC Children’s Hospital. Present the findings as a poster and write a manuscript suitable for publication.
  • Complete an MUE, if not completed in the PGY1 year.

While not required, the initial selection process generally begins at the ASHP Midyear Clinical Meeting in the Personnel Placement Service (PPS). The RPD will meet with potential candidates.

Resident candidates must complete an application via the PhORCAS online application system by midnight on January 3. The completed application includes:

  1. Letter of intent (in PhORCAS)
  2. Curriculum vitae (CV; in PhORCAS). The CV should include a list of rotations completed in the Doctor of Pharmacy program as well as those completed and planned in the PGY1 residency. The length of each rotation should be clear.
  3. Three letters of reference completed by a health care professional who can attest to the applicant’s practice abilities and aptitudes (in PhORCAS). Reference letter writers should be instructed to complete the COMMENTS section for at least five of the characteristics rated in PhORCAS.
  4. Official transcripts of all professional pharmacy education.

Interviews are offered to qualified candidates after applications are reviewed by the pediatric clinical pharmacy group.

After all interviews are completed, the pediatric clinical pharmacy group will rank candidates for submission to the matching service.

A process by which MUSC PGY1 Pharmacy Practice residents may early commit to the PGY2 Pediatric Pharmacy residency is available in the Residency Manual.